Cognition Therapeutics (NASDAQ: CGTX)
$1.93
(-3.0%)
-$0.06
Price as of April 25, 2024, 3:59 p.m. ET
Cognition Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cognition Therapeutics Company Info
Cognition Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for central nervous system disorders. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.